The Institute of Molecular and Genomic Medicine was founded in May 2011 by reorganizing the Division of Molecular and Genomic Medicine, which had been established in 1997. The institute is tasked with developing outstanding research programs to better understand the molecular and genetic basis of diseases prevalent in Taiwan, with an eventual goal of providing better strategies for the detection, treatment, and prevention of those diseases. It has been working toward this goal by establishing state-of-the-art laboratories at NHRI, by conducting disease-related basic and applied research, and by collaborating with researchers nationwide and abroad. The institute is forming distinct but integrated research groups and developing emerging molecular and genetic techniques, as well as various animal models to meet the challenges of medical research of the twenty-first century.

Comments are closed.